Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Brent D. G. Page, Nicholas C. K. Valerie, Roni H. G. Wright, Olov Wallner, Rebecka Isaksson, Megan Carter, Sean G. Rudd, Olga Loseva, Ann-Sofie Jemth, Ingrid Almlöf, Jofre Font-Mateu, Sabin Llona-Minguez, Pawel Baranczewski, Fredrik Jeppsson, Evert Homan, Helena Almqvist, Hanna Axelsson, Shruti Regmi, Anna-Lena Gustavsson, Thomas Lundbäck, Martin Scobie, Kia Strömberg, Pål Stenmark, Miguel Beato, Thomas Helleday |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8af88760aa3d4c38b6df8ba59624e3f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
por: Brent D. G. Page, et al.
Publicado: (2018) -
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir
por: Rina Nishii, et al.
Publicado: (2021) -
NUDT2 initiates viral RNA degradation by removal of 5′-phosphates
por: Beatrice T. Laudenbach, et al.
Publicado: (2021) -
Polyphosphate degradation by Nudt3-Zn2+ mediates oxidative stress response
por: Bàrbara Samper-Martín, et al.
Publicado: (2021) -
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
por: Kanyarat Khaeso, et al.
Publicado: (2021)